Lilly rides Mounjaro, Zepbound to better-than-expected 1Q profit despite supply issues
Tuesday, April 30th 2024, 3:07:16 pm
article
Rapidly climbing sales of the new obesity drug Zepbound and its counterpart for diabetes, Mounjaro, pushed Eli Lilly to a better-than-expected first-quarter profit
Breaking
ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero...
The Department of Homeland Security touted a historic October, reporting a record-low number of border crossings for any October in history....
After all the tariffs, boycotts, and bruised egos, both countries have been left to reckon with lasting economic scars and shifting allegiances....
